| 2026-09-11 16:28 |
8-K |
["1.01", "3.02", "5.03", "9.01"] |
material agreement |
0.15
|
P3 Health Partners raises $70M preferred stock from CPF; standstill extended to Dec 2027—financing, not M&A. |
SEC · detail |
| 2026-08-10 16:03 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine quarterly earnings announcement with no M&A-related disclosures or signals. |
SEC · detail |
| 2026-07-06 17:02 |
8-K |
["1.01", "9.01"] |
other |
0.05
|
Amendment to existing debt repurchase note extending maturity and adjusting interest terms; no M&A signal. |
SEC · detail |
| 2026-06-09 17:54 |
8-K |
["5.07", "9.01"] |
other |
0.05
|
Routine 8-K reporting 2026 Annual Meeting voting results and director elections; no M&A signals. |
SEC · detail |
| 2026-05-26 16:06 |
8-K |
["3.01", "9.01"] |
other |
0.05
|
Nasdaq delisting compliance notice; no M&A signals present. |
SEC · detail |
| 2026-05-15 16:58 |
8-K |
["3.01", "8.01", "9.01"] |
other |
0.15
|
Debt restructuring and equity raise to regain Nasdaq compliance; no M&A signals detected. |
SEC · detail |
| 2026-05-14 16:10 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine quarterly earnings announcement with no M&A, strategic review, or transaction indicators. |
SEC · detail |
| 2026-04-28 17:29 |
8-K |
["1.01", "3.02", "5.03"] |
material agreement |
0.15
|
Debt-to-equity restructuring with major shareholder CPF to restore Nasdaq compliance; no M&A signal. |
SEC · detail |